Healthcare & Pharmaceuticals Industry Press Releases

Published on May 29, 2025 - 12:00 GMT

Beghou Consulting Adds New Partners to Strengthen Market Access, Cell & Gene Therapy, and Technology Capabilities

EVANSTON, Ill., May 29, 2025 (GLOBE NEWSWIRE) -- Beghou Consulting, a leading provider of data, analytics, and technology solutions for life sciences commercialization, today announced that highly-regarded industry leaders Robert Rouse and Jason Stephani …

Distribution channels:

Published on May 29, 2025 - 12:00 GMT

SweetWater Brewing and Zoo Atlanta Celebrate 18 Years of Collaboration with a Special Edition Beer

ATLANTA, May 29, 2025 (GLOBE NEWSWIRE) -- SweetWater Brewing Company (“SweetWater Brewing” or “SweetWater”), the largest craft brewer in the Southeast and a Tilray Brands, Inc. company (NASDAQ: TLRY and TSX: TLRY) is thrilled to extend their partnership …

Distribution channels: Companies, Culture, Society & Lifestyle ...

Published on May 29, 2025 - 12:00 GMT

Safety Shot Reminds Shareholders to Vote Their Proxy at the Upcoming Annual Shareholder Meeting

SCOTTSDALE, Ariz., May 29, 2025 (GLOBE NEWSWIRE) -- Safety Shot, Inc. (Nasdaq: SHOT) (“SHOT”, "Safety Shot”, or the “Company”), a wellness and dietary supplement company, reminds shareholders that its Annual Shareholders’ Meeting will be held on …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on May 29, 2025 - 12:00 GMT

Digital Landia, LLC, in Cooperation with PetVivo Holdings, Inc., Announces Invite-Only MVP Availability Amid Stress-Testing & ...

MIAMI, FL, May 29, 2025 (GLOBE NEWSWIRE) -- Digital Landia, LLC (“Digital Landia”), owner of Agentic.Pet, an autonomous pet artificial intelligence ecosystem, in cooperation with PetVivo Holdings, Inc. (OTCQB: PETV; OTCPINK: PETVW) and its wholly owned …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on May 29, 2025 - 11:55 GMT

Alumis Completes Enrollment of Pivotal Phase 3 ONWARD Clinical Program of Lead Candidate ESK-001, a Highly Selective, Next-...

SOUTH SAN FRANCISCO, Calif., May 29, 2025 (GLOBE NEWSWIRE) -- Alumis Inc. (Nasdaq: ALMS), a late-stage biopharma company developing next-generation targeted therapies for patients with immune-mediated diseases, today announced the completion of patient …

Distribution channels: Healthcare & Pharmaceuticals Industry, Technology ...

Published on May 29, 2025 - 11:30 GMT

Context Therapeutics to Appoint Dr. Karen Chagin, M.D. as Chief Medical Officer

PHILADELPHIA, May 29, 2025 (GLOBE NEWSWIRE) -- Context Therapeutics Inc. (“Context” or “Company”) (Nasdaq: CNTX), a clinical-stage biopharmaceutical company advancing T cell engaging bispecific antibodies for solid tumors, today announced the appointment …

Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...

Published on May 29, 2025 - 11:30 GMT

Maze Therapeutics to Participate in the Jefferies 2025 Global Healthcare Conference

SOUTH SAN FRANCISCO, Calif., May 29, 2025 (GLOBE NEWSWIRE) -- Maze Therapeutics, Inc. (Nasdaq: MAZE), a clinical-stage biopharmaceutical company developing small molecule precision medicines for patients with renal, metabolic and cardiovascular diseases, …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...

Published on May 29, 2025 - 11:30 GMT

Crescent Biopharma to Present at the Jefferies Global Healthcare Conference

WALTHAM, Mass., May 29, 2025 (GLOBE NEWSWIRE) -- Crescent Biopharma, Inc. (“Crescent”), a private biotechnology company developing novel precision-engineered molecules targeting validated biology to advance care for patients with solid tumors, today …

Distribution channels:

Published on May 29, 2025 - 11:30 GMT

Apogee Therapeutics to Participate at the Jefferies Global Healthcare Conference

SAN FRANCISCO and BOSTON, May 29, 2025 (GLOBE NEWSWIRE) -- Apogee Therapeutics, Inc., (Nasdaq: APGE), today announced that members of management will participate in a fireside chat at the Jefferies Global Healthcare Conference on Thursday, June 5, 2025, at …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...

Published on May 29, 2025 - 11:30 GMT

Incannex Healthcare Inc. Advances IHL-42X RePOSA Trial to Phase 3 Following FDA Protocol Clearance

NEW YORK and MELBOURNE, Australia, May 29, 2025 (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (Nasdaq: IXHL), a clinical-stage pharmaceutical company developing novel combination therapies, today announced that the Phase 3 component of the RePOSA clinical …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on May 29, 2025 - 11:05 GMT

uniQure Presents Clinical Case Study of First Patient Dosed with AMT-260 in Refractory Mesial Temporal Lobe Epilepsy (MTLE)

~ No serious adverse events and 92% reduction in seizure frequency observed in the first trial participant through first five months of follow up ~ ~ Data to be presented today at Epilepsy Therapies & Diagnostics Development Symposium (ETDD) ~ …

Distribution channels: Healthcare & Pharmaceuticals Industry, Technology ...

Published on May 29, 2025 - 11:05 GMT

Zenas BioPharma to Present at the Jefferies Global Healthcare Conference

WALTHAM, Mass., May 29, 2025 (GLOBE NEWSWIRE) -- Zenas BioPharma, Inc. (“Zenas” or the “Company”) (Nasdaq: ZBIO), a clinical-stage global biopharmaceutical company committed to being a leader in the development and commercialization of therapies for …

Distribution channels:

Published on May 29, 2025 - 11:00 GMT

RCP calls for action to fix broken medical training system and protect patient care

Dr Mumtaz Patel, RCP president said: ‘Doctors entering medical school in the UK should not have to worry about whether there will be a job for them after foundation training. Through our next generation campaign, we are actively exploring ways in which we …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on May 28, 2025 - 23:00 GMT

Male Infertility Market Projected to Reach 6.62 Billion by 2033 | DataM Intelligence

Male infertility market size reached US$ 4.33 Bn in 2024 and is expected to reach US$ 6.62 Bn by 2033, growing at a CAGR of 4.9% during 2025-2033. NEW YORK, NY, UNITED STATES, May 29, 2025 /⁨EINPresswire.com⁩/ -- The global male infertility market …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on May 29, 2025 - 11:00 GMT

Seer Redefining Deep Unbiased Proteomics with Launch of New Proteograph Workflow at ASMS 2025, Enabling Previously Unattainable ...

REDWOOD CITY, Calif., May 29, 2025 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced the launch of its new Proteograph® Product Suite, featuring the Proteograph ONE Assay …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...

Published on May 29, 2025 - 11:00 GMT

Tilray Brands to Present at TD Cowen’s 9th Annual Future of the Consumer Conference

NEW YORK and LEAMINGTON, Ontario, May 29, 2025 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray”) (NASDAQ: TLRY and TSX: TLRY), a global lifestyle and consumer packaged goods company at the forefront of the beverage, cannabis and wellness industries, today …

Distribution channels:

Published on May 29, 2025 - 11:00 GMT

Syndax Announces Participation in June Investor Conferences

NEW YORK, May 29, 2025 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company advancing innovative cancer therapies, today announced that Michael A. Metzger, Chief Executive Officer of Syndax, as well as …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...

Published on May 29, 2025 - 11:00 GMT

Roivant Reports Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2025, and Provides Business Update

BASEL, Switzerland and LONDON and NEW YORK, May 29, 2025 (GLOBE NEWSWIRE) -- Roivant (Nasdaq: ROIV) today reported its financial results for the fourth quarter and fiscal year ended March 31, 2025, and provided a business update. Brepocitinib program …

Distribution channels:

Published on May 29, 2025 - 11:00 GMT

Axsome Therapeutics to Participate in Upcoming Investor Conferences

NEW YORK, May 29, 2025 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today announced that it will participate in three upcoming …

Distribution channels:

Published on May 29, 2025 - 11:00 GMT

BioStem Technologies to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference

POMPANO BEACH, Fla., May 29, 2025 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC: BSEM), a leading MedTech company focused on the development, manufacturing, and commercialization of placental-derived products for advanced wound care, announces that …

Distribution channels:

Healthcare & Pharmaceuticals Industry Press Releases Distributed by EIN Presswire